DK1427436T3 - Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion - Google Patents

Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion

Info

Publication number
DK1427436T3
DK1427436T3 DK02796345T DK02796345T DK1427436T3 DK 1427436 T3 DK1427436 T3 DK 1427436T3 DK 02796345 T DK02796345 T DK 02796345T DK 02796345 T DK02796345 T DK 02796345T DK 1427436 T3 DK1427436 T3 DK 1427436T3
Authority
DK
Denmark
Prior art keywords
mixture
viral infection
microbial
prophylaxis
treatment
Prior art date
Application number
DK02796345T
Other languages
English (en)
Inventor
Michael Anthony Folan
Damien Brady
Original Assignee
Westgate Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westgate Biolog Ltd filed Critical Westgate Biolog Ltd
Application granted granted Critical
Publication of DK1427436T3 publication Critical patent/DK1427436T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK02796345T 2001-08-23 2002-08-20 Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion DK1427436T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES20010780 2001-08-23
PCT/IE2002/000121 WO2003018049A2 (en) 2001-08-23 2002-08-20 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection

Publications (1)

Publication Number Publication Date
DK1427436T3 true DK1427436T3 (da) 2008-10-13

Family

ID=11042830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02796345T DK1427436T3 (da) 2001-08-23 2002-08-20 Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion

Country Status (15)

Country Link
US (2) US7687074B2 (da)
EP (1) EP1427436B1 (da)
JP (1) JP4532900B2 (da)
KR (1) KR100907959B1 (da)
CN (1) CN1578670B (da)
AT (1) ATE399562T1 (da)
AU (1) AU2002356112B2 (da)
CA (1) CA2458146C (da)
DE (1) DE60227389D1 (da)
DK (1) DK1427436T3 (da)
ES (1) ES2309228T3 (da)
NZ (1) NZ531639A (da)
PT (1) PT1427436E (da)
RU (1) RU2305547C2 (da)
WO (1) WO2003018049A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
MX2007000208A (es) * 2004-07-01 2007-08-07 Schepens Eye Res Inst Composiciones y metodos para tratar trastornos y condiciones del ojo.
BRPI0616323A2 (pt) * 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
AU2006318655B2 (en) * 2005-11-18 2013-03-28 Glanbia Nutritionals (Ireland) Ltd. Compositions for disrupting and inhibiting reconstitution of wound biofilm
JP5017531B2 (ja) * 2006-09-11 2012-09-05 株式会社アップウェル 口内清浄剤
JP2011505415A (ja) * 2007-12-04 2011-02-24 ウエストゲート・バイオロジカル・リミテッド 遊離脂肪酸のブレンド及びその使用
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
US20110098358A1 (en) * 2008-06-11 2011-04-28 Ricom Corporation Human beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same
US20090311236A1 (en) * 2008-06-11 2009-12-17 Immune @Work, Inc. Therapeutic Peptide Compositions And Methods Of Making And Using Same
US8808345B2 (en) * 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
WO2010082587A1 (ja) * 2009-01-13 2010-07-22 株式会社大気倶楽部 空中懸濁物吸着剤
KR101119538B1 (ko) * 2009-06-10 2012-02-22 장선호 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물
ES2643862T3 (es) * 2009-11-17 2017-11-24 Michael Anthony Folan Composiciones antimicrobianas que contienen ácidos grasos libres
UY33548A (es) * 2010-08-06 2012-02-29 Eurand Pharmaceuticals Inc Formula nutricional predigerida
KR101355018B1 (ko) * 2010-12-13 2014-01-24 노부오 구보 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물
RU2494726C2 (ru) * 2011-04-11 2013-10-10 Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
CA3026402A1 (en) 2017-12-05 2019-06-05 James F. Kane Water-soluble cannabinoids and methods of making same
US11298379B2 (en) * 2020-04-16 2022-04-12 James F. Kane Compositions comprising milk fat globules and methods of making same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2796378A (en) * 1954-04-09 1957-06-18 Jr Edgar A Ferguson Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide
GB1050756A (da) * 1964-09-10 1900-01-01
US4397927A (en) * 1982-03-25 1983-08-09 Brog Roy A Imitation milk compositions and aqueous dispersions prepared therefrom
WO1986004217A2 (en) * 1985-01-18 1986-07-31 Kailash Kumar Gauri Protein hydrolysates, production process and drugs containing th em
JPS62249931A (ja) 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
JPH085798B2 (ja) 1987-02-02 1996-01-24 紀夫 多田 抗菌剤
DE69003014T2 (de) * 1989-06-07 1993-12-16 Kao Corp Essbare Öl-in-Wasser-Emulsion.
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
JPH04159232A (ja) * 1990-08-21 1992-06-02 Yakult Honsha Co Ltd 日和見感染症予防・治療用経口組成物
CA2094570A1 (en) 1992-05-27 1993-11-28 Jerome F. Trumbetas Enzymatic protein process and product
AU5896194A (en) 1992-10-30 1994-05-24 Cancer Research Fund Of Contra Costa Anti-diarrheic product and method of treating rotavirus-associated infection
US5785984A (en) * 1993-02-05 1998-07-28 Kao Corporation Taste-modifying method and bitterness-decreasing method
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
CA2197659C (en) * 1994-08-16 2009-11-10 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
JP4233615B2 (ja) * 1996-08-22 2009-03-04 森永乳業株式会社 経口抗ヒト爪白癬及び／又は爪白癬以外のヒト足部白癬用医薬品
JP3819441B2 (ja) * 1997-01-09 2006-09-06 森永乳業株式会社 ラクトフェリン錠剤
IE970541A1 (en) 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
NZ509101A (en) 1998-06-26 2003-07-25 N Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
GB9903584D0 (en) 1999-02-18 1999-04-07 Univ Leeds Modified calycins
JP3662445B2 (ja) * 1999-06-30 2005-06-22 花王株式会社 油中水型乳化油脂組成物
DE60210602T2 (de) * 2001-05-23 2007-05-16 Nutricopia, Inc. Gefrorene ernährungssüssspeisen und verfahren zu ihrer herstellung
US20030165606A1 (en) 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
EP1319407A1 (en) 2001-12-14 2003-06-18 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Also Published As

Publication number Publication date
NZ531639A (en) 2006-02-24
US7972629B2 (en) 2011-07-05
US7687074B2 (en) 2010-03-30
CN1578670A (zh) 2005-02-09
EP1427436B1 (en) 2008-07-02
CA2458146A1 (en) 2003-03-06
KR100907959B1 (ko) 2009-07-16
JP2005501863A (ja) 2005-01-20
EP1427436A2 (en) 2004-06-16
WO2003018049A2 (en) 2003-03-06
RU2305547C2 (ru) 2007-09-10
PT1427436E (pt) 2008-09-08
CA2458146C (en) 2012-07-24
US20100209526A1 (en) 2010-08-19
JP4532900B2 (ja) 2010-08-25
ATE399562T1 (de) 2008-07-15
WO2003018049A3 (en) 2003-11-06
RU2004108040A (ru) 2005-09-27
AU2002356112B2 (en) 2007-11-08
KR20040041579A (ko) 2004-05-17
ES2309228T3 (es) 2008-12-16
DE60227389D1 (de) 2008-08-14
CN1578670B (zh) 2013-09-04
US20050042299A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
DK1427436T3 (da) Anvendelse af mælkeserumapoproteiner til profylakse eller behandling af mikrobiel eller viral infektion
MX2012007410A (es) Compuestos antivirales novedosos.
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
US20110020279A1 (en) Rabies cure
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
WO2004033479A3 (en) Retroyclins: antiviral and antimicrobial peptides
HU230002B1 (en) Use of l-carnitine for preparation of compositions for stabilizing the proteins
CA2489208A1 (en) Interleukin-6 suppressive agent
CN114712355B (zh) Rhps4在制备抑制金黄色葡萄球菌和铜绿假单胞菌药物中的应用
WO2019139228A8 (en) Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes cystatin, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
Bawaskar et al. Aphasia in a farmer after viper bite
NZ587372A (en) Treatment of bacterial, protozoan infections and cancer with a mixture of at least three different human interferon alpha proteins
US20140329780A1 (en) Inhibitor of colonisation of mucosa
YU66099A (sh) Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma
RU2180532C2 (ru) Способ лечения папилломатоза
Pelaz et al. Haematoma of the floor of the mouth associated to acute myocardial infarction
FR3085679B1 (fr) Composes analogues de la squalamine et leur utilisation medicale
SE9903610D0 (sv) Novel compounds II
JP2001187746A (ja) 壊死性感染症の治療
李敏 CLINICAL OBSERVATION ON POSTHERPETIC NEURALGIA OF HIV CARRIERS TREATED WITH ARRANGED ELECTRO ACUPUNCTURE
WO2003035058A3 (en) Polymaleide compounds and their medical use
TH77900A (th) ส่วนบอดี้ที่มีฟอสเฟต-กลีเซอรอลที่สามารถยอมรับได้ทางเภสัชกรรม
TH64256A3 (th) องค์ประกอบของโปรตีนที่ถูกทำให้เสถียร